Hypofractionated Dose Escalation Radiotherapy for High-Risk Prostate Cancer: the survival analysis of the Prostate Cancer Study-5 (PCS-5), a GROUQ-led phase III trial

Autor: Niazi, Tamim, Nabid, Abdenour, Malagon, Talia, Tisseverasinghe, Steven, Bettahar, Redouane, Dahmane, Rafika, Martin, Andre-Guy, Jolicoeur, Marjory, Yassa, Michael, Barkati, Maroie, Igidbashian, Levon, Bahoric, Boris, Archambault, Robert, Villeneuve, Hugo, Mohiuddin, Md
Zdroj: In European Urology August 2024
Databáze: ScienceDirect